Mitsubishi UFJ Asset Management’s Cellectis CLLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-33,595
Closed -$153K 1152
2022
Q1
$153K Buy
33,595
+1,988
+6% +$10.9K ﹤0.01% 1095
2021
Q4
$277K Buy
31,607
+11,858
+60% +$117K ﹤0.01% 1025
2021
Q3
$249K Buy
19,749
+538
+3% +$7.45K ﹤0.01% 1029
2021
Q2
$297K Buy
19,211
+2,433
+15% +$40.9K ﹤0.01% 1042
2021
Q1
$339K Buy
16,778
+5,312
+46% +$131K ﹤0.01% 942
2020
Q4
$310K Buy
11,466
+2,631
+30% +$59K ﹤0.01% 898
2020
Q3
$163K Sell
8,835
-203
-2% -$3.6K ﹤0.01% 917
2020
Q2
$161K Buy
+9,038
New +$138K ﹤0.01% 913
2019
Q4
Sell
-7,925
Closed -$82K 1021
2019
Q3
$82K Buy
7,925
+1,407
+22% +$18.9K ﹤0.01% 924
2019
Q2
$102K Sell
6,518
-480
-7% -$8.57K ﹤0.01% 915
2019
Q1
$128K Buy
6,998
+453
+7% +$8.03K ﹤0.01% 850
2018
Q4
$109K Buy
6,545
+1,787
+38% +$41.4K ﹤0.01% 837
2018
Q3
$134K Buy
+4,758
New +$137K ﹤0.01% 817

Other funds holding CLLS

Mitsubishi UFJ Asset Management's CLLS Position: Q2 2022 in Review

Mitsubishi UFJ Asset Management sold out of Cellectis (CLLS) in Q2 2022, closing a stake of 33,595 shares — an estimated $153K sold.

Mitsubishi UFJ Asset Management first reported a position in CLLS in Q3 2018 and held it in 13 quarters. The position peaked at $339K in Q1 2021. 45 funds tracked by Wall St. Rank hold CLLS as of Q2 2022.

  • Mitsubishi UFJ Asset Management reported no remaining Cellectis position as of Q2 2022 after selling out during the quarter.
  • Mitsubishi UFJ Asset Management sold 33,595 Cellectis shares in Q2 2022, an estimated $153K.
  • Mitsubishi UFJ Asset Management first reported a position in Cellectis in Q3 2018 and held it in 13 quarters.
  • Mitsubishi UFJ Asset Management's Cellectis position peaked at $339K in Q1 2021.
  • 45 funds tracked by Wall St. Rank held Cellectis as of Q2 2022.

Based on Mitsubishi UFJ Asset Management's 13F filing for Q2 2022, filed 4 Aug 2022.